Chronic Lower Back Pain Treatment Market Outlook
According to the report by Expert Market Research (EMR), the global chronic lower back pain treatment market growth, reached a value of USD 7.9 billion in 2023. Aided by the growing global population suffering from chronic lower back pain and the surge in advanced treatments, the market is projected to further grow at a CAGR of 4.90% between 2024 and 2032 to reach a value of USD 12.38 billion by 2032.
Chronic lower back pain is a prolonged, persistent condition impacting the lumbar region of the spine. The condition’s treatment spans a broad array of methods including physiotherapy, medication, surgery, and lifestyle modifications. These treatments aim to reduce pain, restore function, and prevent future recurrences. Apart from its direct impact on physical health, chronic lower back pain often leads to psychological distress, underscoring the importance of effective treatments.
Request a free sample copy in PDF or view the report summary@ https://www.expertmarketresearch.com/reports/chronic-lower-back-pain-treatment-market/requestsample
The rise in the global population suffering from chronic lower back pain is a key driver propelling the chronic lower back pain treatment market growth. With sedentary lifestyles, obesity, and aging populations contributing to the prevalence of chronic lower back pain, there’s been an increased demand for effective treatments. Moreover, occupational hazards in jobs demanding physical exertion or long hours of sitting also contribute to the high incidence of this condition.
The broadening array of chronic lower back pain treatments also significantly contributes to the chronic lower back pain treatment market expansion. In the pharmaceutical sector, a range of drugs from nonsteroidal anti-inflammatory drugs (NSAIDs) to opioids are used to manage pain. The emergence of novel drug therapies with fewer side effects and better efficacy further propels the market.
The healthcare industry’s advancements in surgical interventions and the increased availability of minimally invasive procedures have revolutionised chronic lower back pain treatment. These procedures, offering faster recovery times and less postoperative discomfort, are increasingly popular among patients and physicians alike.
Furthermore, the rising awareness about the importance of lifestyle modifications in managing chronic lower back pain boosts the chronic lower back pain treatment market. Increasing recognition of the benefits of regular exercise, proper ergonomics, and maintaining a healthy weight contributes to this sector’s growth.
In addition, the increasing investments in research and development activities to discover novel treatment options further spur market expansion. With ongoing trials exploring innovative drug therapies and improved surgical techniques, the future of the chronic lower back pain treatment market appears promising.
Explore the full report with the table of contents@ https://www.expertmarketresearch.com/reports/chronic-lower-back-pain-treatment-market
Chronic Lower Back Pain Treatment Market Segmentation
The market can be divided based on pain type, diagnosis, treatment channel, and region.
Market Breakup by Pain Type
- Discogenic Pain
- Lumbar Spinal Stenosis
- Sacroiliac Pain
- Facet- Joint Pain
- Radicular Pain
- Muscular Pain
- Others
Market Breakup by Diagnosis
- Clinical History
- Physical Examination
- Imaging Guidelines
- Others
Market Breakup by Treatment Channel
- Public
- Private
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Competitive Landscape
The EMR report looks into the market shares, plant turnarounds, capacities, investments, and acquisitions and mergers, among other major developments, of the global chronic lower back pain treatment companies. Some of the major key players explored in the report by Expert Market Research are as follows:
- Johnson & Johnson
- Pfizer Inc.
- Sanofi S.A.
- Merck & Co., Inc.
- Medtronic plc
- Endo International plc
- Boston Scientific Corporation
- Koninklijke Philips N.V.
- Karl Storz SE & Co. KG
- Stryker Corporation
About Us:
Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.
Our high-quality, data-driven analyses provide the essential framework for organisations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organisation remains agile, proactive, and poised for success in today’s competitive market.
Don’t miss the opportunity to elevate your business intelligence and fortify your strategic planning. Secure your organisation’s future success by acquiring one of our Expert Market Research reports today.
Media Contact:
Company Name: Claight Corporation
Contact Person: Joe Goldberg, Business Consultant
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com
